Your browser doesn't support javascript.
loading
Rituximab as front-line treatment in refractory autoimmune hemolytic anemia.
Moriki, Dafni; Karalexi, Maria A; Kekkou, Kassiani; Kalogiannis, Michalis; Papaevangelou, Vassiliki; Petrocheilos, Ioannis.
Afiliação
  • Moriki D; Third Department of Pediatrics, General University Hospital "Attikon, " National and Kapodistrian University of Athens, Athens, Greece.
  • Karalexi MA; Third Department of Pediatrics, General University Hospital "Attikon, " National and Kapodistrian University of Athens, Athens, Greece - marykaralexi@windowslive.com.
  • Kekkou K; Third Department of Pediatrics, General University Hospital "Attikon, " National and Kapodistrian University of Athens, Athens, Greece.
  • Kalogiannis M; Third Department of Pediatrics, General University Hospital "Attikon, " National and Kapodistrian University of Athens, Athens, Greece.
  • Papaevangelou V; Third Department of Pediatrics, General University Hospital "Attikon, " National and Kapodistrian University of Athens, Athens, Greece.
  • Petrocheilos I; Third Department of Pediatrics, General University Hospital "Attikon, " National and Kapodistrian University of Athens, Athens, Greece.
Minerva Pediatr (Torino) ; 74(6): 801-802, 2022 12.
Article em En | MEDLINE | ID: mdl-31729205
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anemia Hemolítica Autoimune Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anemia Hemolítica Autoimune Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article